Serum Institute of India CEO Adar Poonawalla spoke to NDTV on a range of issues, key among them the vaccine for malaria and ...

India experiences the world’s absolute burden of at least 11 NTDs, including hookworm, dengue, lymphatic filariasis, leprosy, ...

Don’t look now but the Dengvaxia cases and controversy are beginning to boomerang and may end up landing at the feet or face of those who started it.

The Department of Justice (DOJ) has ordered the withdrawal of cases against former Department of Health (DOH) secretary and ...

Amid rising cases of dengue and the spread of health misinformation, healthcare professionals are calling on Filipinos to seek medical advice and factual information about second-generation dengue ...

This came a week after Dengvaxia manufacturer Sanofi warned that the vaccine may cause severe diseases in the long run for those who have not been infected by dengue prior to the vaccination.—LDF, GMA ...

Researchers believe the innovative idea holds immense promise for tackling a wide range of diseases including cancer through ...

THE Public Attorney’s Office (PAO) has filed a motion for reconsideration with the Department of Justice (DOJ), seeking the ...

Our changing climate creates conditions ripe for the replication of mosquitoes and transmission of diseases they carry. Read ...

Serum Institute of India is planning to introduce chikungunya and monkeypox vaccines in about a year and a half and a dengue vaccine in approximately three years. The company is focusing on vaccine ...